How to cite this paper
Dąbrowska-Maś, E & Raś, W. (2017). Metronidazole citrate ester as the new prodrug of metronidazole.Current Chemistry Letters, 6(4), 167-176.
Refrences
1 Moreno S. N., Mason R. P., Muniz R. P., Cruz F. S. and Docampo R. (1983) Generation of free radicals from metronidazole and other nitroimidazoles by Tritrichomonas foetus. J. Biol. Chem. 258(7), 4051-4054.
2 Lobo V., Patil A., Phatak A. and Chandra N. (2010) Free radicals, antioxidants and functional foods: Impact on human health. Phcog. Rev. 4(8), 118-126.
3 Melo M.E. and Ferreira L.C. (1990) Screening the mutagenic activities of commonly used antiparasite drugs by the simultest, a simplified Salmonella/microsome plate incorporation assay. Rev. Inst. Med. trop. S. Paulo, 32(4), 269-274.
4 Fahrig R. and Engelke M. (1997) Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Elsevier, 395(2–3), 215–221
5 Löfmark S., Edlund C. and Nord C. E. (2010) Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections. Clin. Infect. Dis. 50 (Suppl. 1): 16-23.
6 Pfizer Ltd. (1979) Nitroimidazole formulations. GB Patent 2,000,025.
7 Chien Y. W. and Jefferson D. M. (1977) Injectable metronidazole composition. US Patent 4,032,645.
8 Dubey S., Jain V. and Preethi G. B. (2009) Evaluation of lipophilicity, antimicrobial activity and mutagenicity of some novel ester prodrugs of metronidazole. Indian J. Chem., 48B, 1571-1576.
9 Jacob R. M., Regnier G. L. and Crisan C. (1960) Certain nitro imidazolealkanols and acyl derivatives and process. US Patent 2,994,061.
10 Jeanmart C. and Messer M. N. (1972) 1-(2-aminocarbonyloxyethyl)-5-nitro-imidazole derivatives having antiprotozoal activity. US Patent 3,696,116.
11 Gradnik B., Peddrazoli A. and Dall’Asta L. (1970) 1-(Beta-sulphonyloxy-ethyl)-imidazoles. DE Patent 2,030,314.
12 Thorbek P. and Bundgaard H. (1984) Ester of metronidazole with N,N-dimethylglycine and acid addition salt thereof. US Patent 4,482,722.
13 Bowden K. and Izadi J. (1998) Multifunctional derivatives of metronidazole. In II. Famako, Elsevier, 53(1), 58-61.
14 Mahfouz N. M. and Hassan M. A. (2001) Synthesis, chemical and enzymatic hydrolysis, and bioavailability evaluation in rabbits of metronidazole amino acid ester prodrugs with enhanced water solubility. J. Pharmacy and Pharmacology, 53(6), 841–848.
15 Chiyoo M. J. (1984) Amino acid ester of metronidazole. JP Patent 5,918,1261.
16 Whitefield M. and Weinstock M. (1984) Metronidazole and mizonidazole retinoate ester derivs. ES Patent 8,404,679.
17 Cho M. J and Biermacher J. J. (1979) Metronidazole phosphate and salts. US Patent 4,160,827.
18 Cho M. J., Kurtz R. R., Lewis C and Houser D. J. (1982) Metronidazole Phosphate—A Water-Soluble Prodrug for Parenteral Solutions of Metronidazole. J. Pharm. Sci. 71(4), 410-414.
19 Zeb A., Malik I., Rasheed S., Iqbal C. M. and Z. Basha F. (2012) Metronidazole Esters: A New Class of Antiglycation Agents. In Medicinal Chemistry, 8(5), Bentham Science Publishers, 846-852.
20 Wen-Jun M., Peng-Cheng L., Lei S., Huan-Qiu L. and Hai-Liang Z. (2009) Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors. In Bioorg Med Chem., Elsevier, 17(21), 7531–7536.
21 Atsushi H., Hiroyas u S., Madoka N., Hajime S., Sachiko K., Satoshi S. and Tetsuo S. (2005) Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds. Mutagenesis, 20(3), 217-228.
22 Elizondo G., Gonsebatt M. E., Salazar A. M., Lares I., Santiago P., Herrera J., Hong E., Ostrosky-Wegman P. (1996) Genotoxic effects of metronidazole. In Mutation Research/Genetic Toxicology, 370, Elsevier, 75-80.
23 Dubey S., Jain V. and Preethi G. B. (2009) Evaluation of lipophilicity, antimicrobial activity and mutagenicity of some novel ester prodrugs of metronidazole. Indian J. Chem., 48B, 1571-1576.